Premier Inc (PINC)
19.44
-1.28
(-6.16%)
USD |
NASDAQ |
May 07, 16:00
19.44
0.00 (0.00%)
After-Hours: 19:46
Premier Enterprise Value: 2.263B for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 06, 2024 | 2.263B |
May 03, 2024 | 2.241B |
May 02, 2024 | 2.324B |
May 01, 2024 | 2.305B |
April 30, 2024 | 2.283B |
April 29, 2024 | 2.317B |
April 26, 2024 | 2.293B |
April 25, 2024 | 2.275B |
April 24, 2024 | 2.312B |
April 23, 2024 | 2.301B |
April 22, 2024 | 2.304B |
April 19, 2024 | 2.319B |
April 18, 2024 | 2.273B |
April 17, 2024 | 2.255B |
April 16, 2024 | 2.262B |
April 15, 2024 | 2.268B |
April 12, 2024 | 2.308B |
April 11, 2024 | 2.317B |
April 10, 2024 | 2.312B |
April 09, 2024 | 2.374B |
April 08, 2024 | 2.340B |
April 05, 2024 | 2.302B |
April 04, 2024 | 2.313B |
April 03, 2024 | 2.288B |
April 02, 2024 | 2.342B |
Date | Value |
---|---|
April 01, 2024 | 2.360B |
March 28, 2024 | 2.429B |
March 27, 2024 | 2.394B |
March 26, 2024 | 2.368B |
March 25, 2024 | 2.366B |
March 22, 2024 | 2.386B |
March 21, 2024 | 2.395B |
March 20, 2024 | 2.355B |
March 19, 2024 | 2.348B |
March 18, 2024 | 2.392B |
March 15, 2024 | 2.313B |
March 14, 2024 | 2.312B |
March 13, 2024 | 2.300B |
March 12, 2024 | 2.331B |
March 11, 2024 | 2.349B |
March 08, 2024 | 2.336B |
March 07, 2024 | 2.308B |
March 06, 2024 | 2.289B |
March 05, 2024 | 2.280B |
March 04, 2024 | 2.278B |
March 01, 2024 | 2.278B |
February 29, 2024 | 2.281B |
February 28, 2024 | 2.294B |
February 27, 2024 | 2.372B |
February 26, 2024 | 2.331B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.634B
Minimum
Oct 02 2019
5.430B
Maximum
Nov 03 2021
3.661B
Average
4.198B
Median
Apr 12 2023
Enterprise Value Benchmarks
American Shared Hospital Services | 26.92M |
Novo Integrated Sciences Inc | 13.19M |
Astrana Health Inc | 1.495B |
Cryo-Cell International Inc | 79.50M |
P3 Health Partners Inc | 450.62M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 54.30M |
Revenue (Quarterly) | 334.74M |
Total Expenses (Quarterly) | 269.05M |
EPS Diluted (Quarterly) | 0.45 |
Gross Profit Margin (Quarterly) | 66.10% |
Profit Margin (Quarterly) | 16.22% |
Earnings Yield | 7.15% |
Operating Earnings Yield | 9.44% |
Normalized Earnings Yield | 7.152 |